Not applicableStudy completedNCT07052734What this trial is testingMiti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer PatientsWho this might be right forBreast Cancer Sun Yat-sen University 2,843
Testing effectiveness (Phase 2)Looking for participantsNCT06207734What this trial is testingDiscontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast CancerWho this might be right forBreast Cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 120
Very early researchNot Yet RecruitingNCT07671092What this trial is testingImaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLCWho this might be right forMetastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more RayzeBio, Inc. 40
Early research (Phase 1)Looking for participantsNCT06738966What this trial is testingBL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic CancerWho this might be right forBreast CancerOvarian CancerEndometrial Cancer Shanghai Best-Link Bioscience, LLC 9
Testing effectiveness (Phase 2)UnknownNCT03910712What this trial is testingPyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCWho this might be right forBreast Cancer FemaleHER2-positive Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast+3 more Peking Union Medical College Hospital 250
Not applicableStudy completedNCT03921866What this trial is testingUK Ibrance Patient Program (IPP) StudyWho this might be right forHR+/HER2- Locally Advanced, Metastatic Breast Cancer Pfizer 191
Testing effectiveness (Phase 2)Ended earlyNCT01919229What this trial is testingA Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)Who this might be right forEarly Breast Cancer Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)Ended earlyNCT02990845What this trial is testingPembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast CancerWho this might be right forPremenopausal Breast Cancer National Taiwan University Hospital 16
Not applicableStudy completedNCT06003114What this trial is testingUnderstand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other OrgansWho this might be right forBreast Cancer Pfizer 472
Testing effectiveness (Phase 2)Looking for participantsNCT06974604What this trial is testingPreventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DMWho this might be right forBreast NeoplasmsLung Neoplasms Brown University 60
Testing effectiveness (Phase 2)Ended earlyNCT03519178What this trial is testingPF-06873600 in People With CancerWho this might be right forHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Pfizer 155
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948What this trial is testingAdherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast CancerWho this might be right forBreast CancerAdherence, Medication Institute of Oncology Ljubljana 90
Testing effectiveness (Phase 2)UnknownNCT04355520What this trial is testingTQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerWho this might be right forHR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05546268What this trial is testingStudy of Oral MRT-2359 in Selected Cancer PatientsWho this might be right forNSCLCSCLCHigh Grade Neuroendocrine Cancer+5 more Monte Rosa Therapeutics, Inc 174
Testing effectiveness (Phase 2)UnknownNCT02000193What this trial is testingMaintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast CancerWho this might be right forBreast Cancer Sun Yat-sen University 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07317778What this trial is testingChemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast CancerWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3)HR Positive/HER2 Low Breast Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 249
Not applicableStudy completedNCT05584644What this trial is testingDescribe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast CancerWho this might be right forBreast CancerBreast CarcinomaBreast Neoplasms+2 more Pfizer 150
Testing effectiveness (Phase 2)UnknownNCT05430347What this trial is testingClinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast CancerWho this might be right forBreast Cancer The First Affiliated Hospital with Nanjing Medical University 80
Early research (Phase 1)Not Yet RecruitingNCT06941142What this trial is testingSirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerWho this might be right forAdvanced Breast Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 382
Testing effectiveness (Phase 2)Ended earlyNCT04227327What this trial is testingStudy Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)Who this might be right forAdvanced Breast Cancer University of Milano Bicocca 31